To read more on this topic click here.
Plant-based compounds could treat chronic pain in Parkinson’s, study finds
Author: Sophie BatesPublished: 12 March 2020
Prep: Cook: Serves:
A six-year study has found that chronic pain in people with Parkinson’s is linked to a gene involved with how the brain responds to cannabis compounds.
The investigation examined why some people with the condition experience persistent pain – and the impact it has on their work, daily life and social relationships. Conducted by researchers at Manchester’s Salford Royal Foundation Trust, UK, and funded by Parkinson’s UK, it is the largest study to investigate chronic pain in people with Parkinson’s.
Dr Monty Silverdale, consultant neurologist at Greater Manchester Centre, said: “This study is significant because it shows the important role of genetics in chronic pain in Parkinson’s.
“Our findings suggest that cannabis-based compounds may be worth investigating as a treatment for pain in Parkinson’s.”
Could playing table tennis help reduce Parkinson’s symptoms?
‘Dopamine-boosting’ BT13 molecule could be used to slow Parkinson’s
Share this story
High-profile MEP supports European inventory research initiative
Parkinson's Europe launches new My PD Journey research projectREAD MORE
Could a horse tranquilliser help treat Parkinson’s?
‘Party drug’ has potential to be repurposed for Parkinson’sREAD MORE
In my country
Parkinson’s in Barbados is “overshadowed by other conditions”
We talk to the founder of Barbados’ only Parkinson’s support groupREAD MORE